Shares of Japanese drugmaker Kobayashi Pharmaceutical Co. extended Monday’s slump after the company said it received a report one of the users of its recalled supplement pills died due to kidney disease.
Kobayashi Pharma Extends Drop on Report a User of Its Pills DiedConsumer Lender Curo Goes Bankrupt as Debt Pile Takes TollBitcoin Volatility Becomes More Intense in US Compared With AsiaTime to shift that parked RRSP contribution into drive'Like throwing money down the drain': Food waste is out as grocery prices rise and budgets tightenDale Jackson: 4 tax tools that can keep more of your money investedTax return software makes filing easy, but knowing when to hire a professional is...
29?Adam Neumann Offers to Buy Back WeWork for More Than $500 Million, WSJ ReportsLondon Homes Still Cost 12 Times Earnings Despite Fall in PricesChina’s Tech Sector May Rival Property as Growth Driver, BE SaysEngland’s Homes Found More Cramped Than Those In New York CityReal Estate Investors Sitting on ‘Huge’ CO2 Risk Turn to LawyersBurned Before, Bond Markets Resume Rate-Cutting Trades WorldwideHong Kong’s Big Estates Post 32% Slump in Weekend TransactionsCountry Garden, Vanke to Expose Extent...
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
AstraZeneca to buy Amolyt Pharma for US$1.05-billion to boost rare-disease portfolioThe deal, which includes an $800-million upfront payment and an additional contingent payment of $250-million on achieving a specified regulatory milestone, is expected to close by the third quarter of 2024
Read more »
KKR Considers Selling Stake in India’s $3 Billion JB Pharma, Sources SayKKR & Co. is exploring options including selling its controlling stake in India’s JB Chemicals & Pharmaceuticals Ltd. amid interest from potential buyers, according to people familiar with the matter.
Read more »
AstraZeneca to buy Fusion Pharma for $2 billion in cashThe drugmaker will pay $21 per Fusion share, a premium of more than 97% to the U.S.-listed company's closing price on Monday. AstraZeneca will also pay a...
Read more »
IFF to sell pharma unit to Roquette for enterprise value of $2.85-billionThe move comes at a time when International Flavors & Fragrances is seeing demand slow for its food ingredients and solutions business
Read more »
Novo Nordisk Agrees to Buy Cardior Pharma for Up to €1 BillionNovo Nordisk A/S agreed to buy Cardior Pharmaceuticals for up to €1 billion ($1.1 billion) as the Danish maker of weight-loss drugs continues to expand into treatments for cardiovascular disease.
Read more »
Iron Ore Extends Slump Below $100 as China Concerns Spur Rout(Bloomberg) -- Iron ore hit the lowest level since last May to trade well below $100 a ton ahead of data from China that may point to further weakness across...
Read more »